Daniel Birnbaum

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

117h-index52.2kcitations1.1kworks1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(139), Cancer Genomics and Diagnostics(126), Breast Cancer Treatment Studies(119), Acute Myeloid Leukemia Research(83), Gene expression and cancer classification(81)

Publications1.1k total

Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
Oncogene·2025Open Access
Does Enhanced Recovery Programs in Liver Surgery Impact Survival? The PRESTIGE Prospective Study Cohort
HPB·2025
A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing
Briefings in Bioinformatics·2024· 6 citedOpen Access
Dasatinib Overcomes AML Resistance to BCL2 Inhibition By Indirectly Inhibiting MCL1: From <i>Ex Vivo</i> drug Sensitivity/Resistance Profiling to a Phase II Clinical Trial: A Hemato-BIO Study
Blood·2024Open Access
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
Journal of Translational Medicine·2024· 1 citedOpen Access
Epigenenomic and transcriptomic characterization of <i>NPM1</i> -mutated CN-AML subtypes
2024Open Access
Mutational landscape of inflammatory breast cancer
Journal of Translational Medicine·2024· 7 citedOpen Access
Deregulated gene expression in relation with DNA methylation profiles associated with Estrogen Receptor (ER) status and breast cancer molecular subtypes
European Journal of Cancer·2024Open Access
Long-term survival of <i>NPM1</i> AML treated with intensive chemotherapy with extensive molecular data available
Leukemia & lymphoma/Leukemia and lymphoma·2024
CXCL1/CXCR2 and CCL5/CCR1/CCR5 Promote Radiation-Induced Reprogramming of Breast Non-cancer Stem Cells into Cancer Stem Cells and Predict Patient Clinical Outcome
Preprints.org·2024· 1 citedOpen Access
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
Journal of Translational Medicine·2023· 6 citedOpen Access
ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines
Pharmaceutics·2023· 3 citedOpen Access
Supplementary Figure from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
2023Open Access
Data from “Wnt/β-Catenin in GIST”—Letter
2023Open Access
Supplementary Figure from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
2023Open Access
Figure S1 from “Wnt/β-Catenin in GIST”—Letter
2023Open Access
Supplementary Table from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
2023Open Access
Supplementary Figure from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
2023Open Access
Supplementary Tables 1-7 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
2023Open Access
Supplementary Figures 1-4 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
2023Open Access
page 1 of 57Next →

Frequent Co-authors

François Bertucci(20), Pascal Finetti(16), Emmanuelle Charafe‐Jauffret(14), Christophe Ginestier(12), Patrice Viens(12), José Adélaı̈de(12), Nathalie Cervera(10), Véronique Gelsi‐Boyer(10), Jocelyne Jacquemier(9), Norbert Vey(9), Max Chaffanet(7), Olivier Bernard(7), Max S. Wicha(6), Luc Xerri(6), Benjamin Esterni(6), Olivier Kosmider(6), François Dreyfus(6), Michaëla Fontenay(6), Sylvie Marchetto(6), Nadine Carbuccia(5)